Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Long-term Debt / Equity

Alexion Pharm Inc Long-term Debt / Equity Chart (ALXN)

Alexion Pharm Inc annual/quarterly Long-term Debt / Equity from 2010 to 2020.
  • Alexion Pharm Inc Long-term Debt / Equity for the quarter ending September 09, 2020 was $25m a 6.42% increase of 2m year over year
  • Alexion Pharm Inc Long-term Debt / Equity for the last 12 months ending September 09, 2020 was $25m a 6.42% increase of 2m year over year
  • Alexion Pharm Inc Annual Long-term Debt / Equity for 2019 was $24m a -33.46% decrease of -8m from 2018
  • Alexion Pharm Inc Annual Long-term Debt / Equity for 2018 was $31m a -9.63% decrease of -3m from 2017
  • Alexion Pharm Inc Annual Long-term Debt / Equity for 2017 was $34m a -4.23% decrease of -1m from 2016
Other Ratios Metrics:
  • Alexion Pharm Inc Total Debt / Capital for the quarter ending December 12, 2018 was $26m a -0.19% decrease of 0m year over year
  • Alexion Pharm Inc Other Liabilities for the quarter ending December 12, 2018 was $730m a -2.27% decrease of -17m year over year
  • Alexion Pharm Inc Total Debt / Equity for the quarter ending December 12, 2018 was $35m a -0.26% decrease of 0m year over year
View Chart On Koyfin

Quarterly ALXN Long-term Debt / Equity Data

09/2020$25m
06/2020$25m
03/2020$23m
12/2019$24m
09/2019$26m
06/2019$27m
03/2019$28m
12/2018$31m
09/2018$32m
06/2018$33m

Annual ALXN Long-term Debt / Equity Data

2019$24m
2018$31m
2017$34m
2016$36m
2015$41m
2014$4m
2013$4m
2012$5m
2010$1m